Related Experiment Video
Updated: Oct 24, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
The NAL-NL3 Prescription
Pádraig T Kitterick1, Jessica J M Monaghan1, Justin A Zakis1
1National Acoustic Laboratories, Sydney, Australia.
Objective:
NAL-NL2 is used worldwide to prescribe hearing aid gain and compression for new and experienced hearing aid users. The NAL-NL3 Prescription was developed to further optimise fitting targets to maximise predicted speech intelligibility without exceeding normal-hearing loudness, and to address clinical feedback about NAL-NL2.
Design:
Clinician reports identified cases where fittings departed from NAL-NL2 targets; clinical records confirmed systematic deviations. Multi-stage non-linear optimisation with constraints on low- and high-frequency gain identified optimal targets. Clinical review guided target refinement for deep neural-network training. Output-stage limiting enforced fast-compression ratio limits. Modelling assessed predicted intelligibility, loudness, and sharpness; in-clinic trials gathered clinician usability ratings.
Study Sample:
76 clinician survey respondents; 1.33 million adult-fitting records; 29 clinicians evaluated usability across 263 adult fittings.
Results:
Model-based evaluation identified statistically significant increases in predicted intelligibility and significant decreases in sharpness while maintaining loudness within normal-hearing limits. Relative to NAL-NL2, gain decreased below 0.5 kHz and above 6 kHz, with modest increases between 1 and 4 kHz. Compression ratios were within desired limits. Clinicians reported improved ease of fitting and fewer fine-tuning adjustments.
Conclusions:
The NAL-NL3 Prescription retains NAL's validated approach to prescribing gain and compression while generating targets with higher predicted intelligibility that are clinically appropriate for a wider range of fittings.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Delivery: Enteral Route
Drugs in...
Drug Nomenclature
Phase I Reactions: Reductive Reactions
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Nucleophilic Aromatic Substitution: Addition–Elimination (SNAr)
The reaction begins with an attack of the nucleophile on the carbon that holds the leaving group. This results in the delocalization of the π electrons over the ring carbons. The resonance interaction between the...
